Compare
Abbott Laboratories vs Inspire Medical Systems (ABT vs INSP)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Inspire Medical Systems (INSP) -22.8%; so far this year the figures are -12.3% and -30.6%.
Abbott Laboratories is the larger company by market value, about 102.9 times the size of Inspire Medical Systems.
On trailing earnings, ABT trades at 40.9 times and INSP at 19.0 times.
Revenue grew +10.0% at ABT and -0.2% at INSP over the last year.
ABT yields 2.29%. INSP pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | INSP | |
|---|---|---|
| Price | $109.93 | $63.98 |
| 1-day | -3.23% | -3.83% |
| YTD | -12.26% | -30.63% |
| 1 year | -11.73% | -22.75% |
| 3 years | +15.70% | -59.07% |
| Market cap | $190.4B | $1.9B |
| P/E | 40.9 | 19.0 |
| P/S | 3.95 | 2.10 |
| P/B | 3.73 | 2.24 |
| Revenue growth | +10.00% | -0.20% |
| EPS growth | -66.20% | +128.60% |
| Gross margin % | 56.9 | 86.2 |
| Net margin % | 9.7 | 11.4 |
| ROE % | 9.2 | 12.2 |
| Debt / equity | 0.61 | 0.03 |
| FCF yield % | 3.5 | 5.3 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.99 |
| RSI (14) | 58.5 | 40.5 |
| Technical rating |